Latest News and Press Releases

Wilmington, Delaware, Aug. 22, 2024 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, "Follicle Stimulating Hormone Market by Type (Recombinant FSH, and Urinary FSH),...

Pune, July 12, 2024 (GLOBE NEWSWIRE) -- Hormone Replacement Therapy Market Analysis: “According to SNS Insider Research, The Hormone Replacement Therapy Market size is valued at US$ 21.97...

Pune, India, April 13, 2023 (GLOBE NEWSWIRE) -- The global hormone replacement therapy market size was USD 13.40 billion in 2020. The market is projected to grow from USD 14.17 billion in 2021 to...

New York, Aug. 02, 2022 (GLOBE NEWSWIRE) -- According to the report published by Next Move Strategy Consulting, the global biopharmaceutical market generated USD 345.84 billion in 2021, and is...

New York, Oct. 27, 2021 (GLOBE NEWSWIRE) -- Metabolomics Services Market: Key InsightsAccording to our new research study on “Metabolomics Services Market Size and Forecast to 2028 - COVID-19 Impact...

PRINCETON, N.J., Sept. 07, 2017 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (NASDAQ:AGRX), a women's healthcare company, today announced that an abstract presenting data from the Phase 3 SECURE...

PRINCETON, N.J., Aug. 03, 2017 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a forward-thinking women’s healthcare company, today announced the pricing of its underwritten public...

Cash Expected to Fund Operations into Q2 2018 FDA Assigns Prescription Drug User Fee Act (PDUFA) Goal Date of December 26, 2017 PRINCETON, N.J., July 28, 2017 (GLOBE NEWSWIRE) -- Agile...

PRINCETON, N.J., July 27, 2017 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a forward-thinking women’s healthcare company, today announced that the U.S. Food and Drug Administration...

PRINCETON, N.J., May 08, 2017 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women's healthcare company today reported financial results for the three months ended March 31, 2017, and...